<?xml version="1.0" encoding="UTF-8"?>
<p id="par0125">Also, for volume and dose there is now no conclusive evidence and the first trials are based on schedules of administration defined in previous epidemics [
 <xref rid="bib0005" ref-type="bibr">1</xref>,
 <xref rid="bib0010" ref-type="bibr">2</xref>,
 <xref rid="bib0040" ref-type="bibr">8</xref>,
 <xref rid="bib0095" ref-type="bibr">19</xref>] and on consensus among experts, as there is no conclusive evidence until now. An administration of volumes from 200 to 600 mL of immune plasma (roughly corresponding to 8â€“10 mL/kg, with a maximum of 600 mL) once per day on up to three consecutive days is suggested. This scheme could be eventually repeated once. Higher volumes could be contraindicated due to the risk of transfusion associated circulatory overload.
</p>
